Mind Medicine (MindMed) is a biopharmaceutical company focused on developing innovative treatments for brain health disorders. Their lead product candidates include MM-120 for generalized anxiety disorder and attention deficit hyperactivity disorder, and MM-402 for core symptoms of autism spectrum disorder. They also have MM-110 in development for opioid withdrawal. The company is based in New York.